The global market for NSAIDs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSAIDs.

The NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of NSAIDs Market Report

Report Metric	Details
Report Name	NSAIDs Market
CAGR	5%
Segment by Type	Aspirin Ibuprofen Naproxen Nabumetone Others
Segment by Application	Back Pain Treatment Osteoarthritis Treatment Other Disease Treatment
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, GlaxoSmithKline, Reddy Pharmaceuticals, Verywell
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the NSAIDs Market report?

Ans: The main players in the NSAIDs Market are Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, GlaxoSmithKline, Reddy Pharmaceuticals, Verywell

What are the Application segmentation covered in the NSAIDs Market report?

Ans: The Applications covered in the NSAIDs Market report are Back Pain Treatment, Osteoarthritis Treatment, Other Disease Treatment

What are the Type segmentation covered in the NSAIDs Market report?

Ans: The Types covered in the NSAIDs Market report are Aspirin, Ibuprofen, Naproxen, Nabumetone, Others

1 NSAIDs Market Overview

1.1 Product Definition

1.2 NSAIDs by Type

1.2.1 Global NSAIDs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Aspirin

1.2.3 Ibuprofen

1.2.4 Naproxen

1.2.5 Nabumetone

1.2.6 Others

1.3 NSAIDs by Application

1.3.1 Global NSAIDs Market Value by Application (2024 VS 2031)

1.3.2 Back Pain Treatment

1.3.3 Osteoarthritis Treatment

1.3.4 Other Disease Treatment

1.4 Global NSAIDs Market Size Estimates and Forecasts

1.4.1 Global NSAIDs Revenue 2020-2031

1.4.2 Global NSAIDs Sales 2020-2031

1.4.3 Global NSAIDs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 NSAIDs Market Competition by Manufacturers

2.1 Global NSAIDs Sales Market Share by Manufacturers (2020-2025)

2.2 Global NSAIDs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global NSAIDs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of NSAIDs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of NSAIDs, Product Type & Application

2.7 Global Key Manufacturers of NSAIDs, Date of Enter into This Industry

2.8 Global NSAIDs Market Competitive Situation and Trends

2.8.1 Global NSAIDs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest NSAIDs Players Market Share by Revenue

2.8.3 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global NSAIDs Market Scenario by Region

3.1 Global NSAIDs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global NSAIDs Sales by Region: 2020-2031

3.2.1 Global NSAIDs Sales by Region: 2020-2025

3.2.2 Global NSAIDs Sales by Region: 2026-2031

3.3 Global NSAIDs Revenue by Region: 2020-2031

3.3.1 Global NSAIDs Revenue by Region: 2020-2025

3.3.2 Global NSAIDs Revenue by Region: 2026-2031

3.4 North America NSAIDs Market Facts & Figures by Country

3.4.1 North America NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America NSAIDs Sales by Country (2020-2031)

3.4.3 North America NSAIDs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe NSAIDs Market Facts & Figures by Country

3.5.1 Europe NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe NSAIDs Sales by Country (2020-2031)

3.5.3 Europe NSAIDs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific NSAIDs Market Facts & Figures by Region

3.6.1 Asia Pacific NSAIDs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific NSAIDs Sales by Region (2020-2031)

3.6.3 Asia Pacific NSAIDs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America NSAIDs Market Facts & Figures by Country

3.7.1 Latin America NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America NSAIDs Sales by Country (2020-2031)

3.7.3 Latin America NSAIDs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa NSAIDs Market Facts & Figures by Country

3.8.1 Middle East and Africa NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa NSAIDs Sales by Country (2020-2031)

3.8.3 Middle East and Africa NSAIDs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global NSAIDs Sales by Type (2020-2031)

4.1.1 Global NSAIDs Sales by Type (2020-2025)

4.1.2 Global NSAIDs Sales by Type (2026-2031)

4.1.3 Global NSAIDs Sales Market Share by Type (2020-2031)

4.2 Global NSAIDs Revenue by Type (2020-2031)

4.2.1 Global NSAIDs Revenue by Type (2020-2025)

4.2.2 Global NSAIDs Revenue by Type (2026-2031)

4.2.3 Global NSAIDs Revenue Market Share by Type (2020-2031)

4.3 Global NSAIDs Price by Type (2020-2031)

5 Segment by Application

5.1 Global NSAIDs Sales by Application (2020-2031)

5.1.1 Global NSAIDs Sales by Application (2020-2025)

5.1.2 Global NSAIDs Sales by Application (2026-2031)

5.1.3 Global NSAIDs Sales Market Share by Application (2020-2031)

5.2 Global NSAIDs Revenue by Application (2020-2031)

5.2.1 Global NSAIDs Revenue by Application (2020-2025)

5.2.2 Global NSAIDs Revenue by Application (2026-2031)

5.2.3 Global NSAIDs Revenue Market Share by Application (2020-2031)

5.3 Global NSAIDs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Company Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bayer NSAIDs Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Novacap

6.2.1 Novacap Company Information

6.2.2 Novacap Description and Business Overview

6.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novacap NSAIDs Product Portfolio

6.2.5 Novacap Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott NSAIDs Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer NSAIDs Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Company Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Johnson & Johnson NSAIDs Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

6.6 Cigna

6.6.1 Cigna Company Information

6.6.2 Cigna Description and Business Overview

6.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Cigna NSAIDs Product Portfolio

6.6.5 Cigna Recent Developments/Updates

6.7 Geri-Care Pharmaceuticals

6.7.1 Geri-Care Pharmaceuticals Company Information

6.7.2 Geri-Care Pharmaceuticals Description and Business Overview

6.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Geri-Care Pharmaceuticals NSAIDs Product Portfolio

6.7.5 Geri-Care Pharmaceuticals Recent Developments/Updates

6.8 Perrigo Company

6.8.1 Perrigo Company Company Information

6.8.2 Perrigo Company Description and Business Overview

6.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Perrigo Company NSAIDs Product Portfolio

6.8.5 Perrigo Company Recent Developments/Updates

6.9 Kopran

6.9.1 Kopran Company Information

6.9.2 Kopran Description and Business Overview

6.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Kopran NSAIDs Product Portfolio

6.9.5 Kopran Recent Developments/Updates

6.10 Merck Sharp & Dohme

6.10.1 Merck Sharp & Dohme Company Information

6.10.2 Merck Sharp & Dohme Description and Business Overview

6.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Merck Sharp & Dohme NSAIDs Product Portfolio

6.10.5 Merck Sharp & Dohme Recent Developments/Updates

6.11 Sun Pharmaceutical Industries

6.11.1 Sun Pharmaceutical Industries Company Information

6.11.2 Sun Pharmaceutical Industries Description and Business Overview

6.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Sun Pharmaceutical Industries NSAIDs Product Portfolio

6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates

6.12 GlaxoSmithKline

6.12.1 GlaxoSmithKline Company Information

6.12.2 GlaxoSmithKline Description and Business Overview

6.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 GlaxoSmithKline NSAIDs Product Portfolio

6.12.5 GlaxoSmithKline Recent Developments/Updates

6.13 Reddy Pharmaceuticals

6.13.1 Reddy Pharmaceuticals Company Information

6.13.2 Reddy Pharmaceuticals Description and Business Overview

6.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Reddy Pharmaceuticals NSAIDs Product Portfolio

6.13.5 Reddy Pharmaceuticals Recent Developments/Updates

6.14 Verywell

6.14.1 Verywell Company Information

6.14.2 Verywell Description and Business Overview

6.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Verywell NSAIDs Product Portfolio

6.14.5 Verywell Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 NSAIDs Industry Chain Analysis

7.2 NSAIDs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 NSAIDs Production Mode & Process Analysis

7.4 NSAIDs Sales and Marketing

7.4.1 NSAIDs Sales Channels

7.4.2 NSAIDs Distributors

7.5 NSAIDs Customer Analysis

8 NSAIDs Market Dynamics

8.1 NSAIDs Industry Trends

8.2 NSAIDs Market Drivers

8.3 NSAIDs Market Challenges

8.4 NSAIDs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Geri-Care Pharmaceuticals

Perrigo Company

Kopran

Merck Sharp & Dohme

Sun Pharmaceutical Industries

GlaxoSmithKline PLC

Reddy Pharmaceuticals

Verywell

List of Tables

Table 1. Global NSAIDs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global NSAIDs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global NSAIDs Market Competitive Situation by Manufacturers in 2024

Table 4. Global NSAIDs Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global NSAIDs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global NSAIDs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global NSAIDs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market NSAIDs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of NSAIDs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of NSAIDs, Product Type & Application

Table 12. Global Key Manufacturers of NSAIDs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global NSAIDs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global NSAIDs Sales by Region (2020-2025) & (K Pcs)

Table 18. Global NSAIDs Sales Market Share by Region (2020-2025)

Table 19. Global NSAIDs Sales by Region (2026-2031) & (K Pcs)

Table 20. Global NSAIDs Sales Market Share by Region (2026-2031)

Table 21. Global NSAIDs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global NSAIDs Revenue Market Share by Region (2020-2025)

Table 23. Global NSAIDs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global NSAIDs Revenue Market Share by Region (2026-2031)

Table 25. North America NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America NSAIDs Sales by Country (2020-2025) & (K Pcs)

Table 27. North America NSAIDs Sales by Country (2026-2031) & (K Pcs)

Table 28. North America NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe NSAIDs Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe NSAIDs Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific NSAIDs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific NSAIDs Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific NSAIDs Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific NSAIDs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific NSAIDs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America NSAIDs Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America NSAIDs Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa NSAIDs Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa NSAIDs Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global NSAIDs Sales (K Pcs) by Type (2020-2025)

Table 51. Global NSAIDs Sales (K Pcs) by Type (2026-2031)

Table 52. Global NSAIDs Sales Market Share by Type (2020-2025)

Table 53. Global NSAIDs Sales Market Share by Type (2026-2031)

Table 54. Global NSAIDs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global NSAIDs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global NSAIDs Revenue Market Share by Type (2020-2025)

Table 57. Global NSAIDs Revenue Market Share by Type (2026-2031)

Table 58. Global NSAIDs Price (USD/Pcs) by Type (2020-2025)

Table 59. Global NSAIDs Price (USD/Pcs) by Type (2026-2031)

Table 60. Global NSAIDs Sales (K Pcs) by Application (2020-2025)

Table 61. Global NSAIDs Sales (K Pcs) by Application (2026-2031)

Table 62. Global NSAIDs Sales Market Share by Application (2020-2025)

Table 63. Global NSAIDs Sales Market Share by Application (2026-2031)

Table 64. Global NSAIDs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global NSAIDs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global NSAIDs Revenue Market Share by Application (2020-2025)

Table 67. Global NSAIDs Revenue Market Share by Application (2026-2031)

Table 68. Global NSAIDs Price (USD/Pcs) by Application (2020-2025)

Table 69. Global NSAIDs Price (USD/Pcs) by Application (2026-2031)

Table 70. Bayer Company Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Bayer NSAIDs Product

Table 74. Bayer Recent Developments/Updates

Table 75. Novacap Company Information

Table 76. Novacap Description and Business Overview

Table 77. Novacap NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Novacap NSAIDs Product

Table 79. Novacap Recent Developments/Updates

Table 80. Abbott Company Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Abbott NSAIDs Product

Table 84. Abbott Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Pfizer NSAIDs Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Johnson & Johnson Company Information

Table 91. Johnson & Johnson Description and Business Overview

Table 92. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Johnson & Johnson NSAIDs Product

Table 94. Johnson & Johnson Recent Developments/Updates

Table 95. Cigna Company Information

Table 96. Cigna Description and Business Overview

Table 97. Cigna NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Cigna NSAIDs Product

Table 99. Cigna Recent Developments/Updates

Table 100. Geri-Care Pharmaceuticals Company Information

Table 101. Geri-Care Pharmaceuticals Description and Business Overview

Table 102. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Geri-Care Pharmaceuticals NSAIDs Product

Table 104. Geri-Care Pharmaceuticals Recent Developments/Updates

Table 105. Perrigo Company Company Information

Table 106. Perrigo Company Description and Business Overview

Table 107. Perrigo Company NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Perrigo Company NSAIDs Product

Table 109. Perrigo Company Recent Developments/Updates

Table 110. Kopran Company Information

Table 111. Kopran Description and Business Overview

Table 112. Kopran NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. Kopran NSAIDs Product

Table 114. Kopran Recent Developments/Updates

Table 115. Merck Sharp & Dohme Company Information

Table 116. Merck Sharp & Dohme Description and Business Overview

Table 117. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Merck Sharp & Dohme NSAIDs Product

Table 119. Merck Sharp & Dohme Recent Developments/Updates

Table 120. Sun Pharmaceutical Industries Company Information

Table 121. Sun Pharmaceutical Industries Description and Business Overview

Table 122. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. Sun Pharmaceutical Industries NSAIDs Product

Table 124. Sun Pharmaceutical Industries Recent Developments/Updates

Table 125. GlaxoSmithKline Company Information

Table 126. GlaxoSmithKline Description and Business Overview

Table 127. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 128. GlaxoSmithKline NSAIDs Product

Table 129. GlaxoSmithKline Recent Developments/Updates

Table 130. Reddy Pharmaceuticals Company Information

Table 131. Reddy Pharmaceuticals Description and Business Overview

Table 132. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 133. Reddy Pharmaceuticals NSAIDs Product

Table 134. Reddy Pharmaceuticals Recent Developments/Updates

Table 135. Verywell Company Information

Table 136. Verywell Description and Business Overview

Table 137. Verywell NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 138. Verywell NSAIDs Product

Table 139. Verywell Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. NSAIDs Distributors List

Table 143. NSAIDs Customers List

Table 144. NSAIDs Market Trends

Table 145. NSAIDs Market Drivers

Table 146. NSAIDs Market Challenges

Table 147. NSAIDs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of NSAIDs

Figure 2. Global NSAIDs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global NSAIDs Market Share by Type: 2024 & 2031

Figure 4. Aspirin Product Picture

Figure 5. Ibuprofen Product Picture

Figure 6. Naproxen Product Picture

Figure 7. Nabumetone Product Picture

Figure 8. Others Product Picture

Figure 9. Global NSAIDs Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global NSAIDs Market Share by Application: 2024 & 2031

Figure 11. Back Pain Treatment

Figure 12. Osteoarthritis Treatment

Figure 13. Other Disease Treatment

Figure 14. Global NSAIDs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global NSAIDs Market Size (2020-2031) & (US$ Million)

Figure 16. Global NSAIDs Sales (2020-2031) & (K Pcs)

Figure 17. Global NSAIDs Average Price (USD/Pcs) & (2020-2031)

Figure 18. NSAIDs Report Years Considered

Figure 19. NSAIDs Sales Share by Manufacturers in 2024

Figure 20. Global NSAIDs Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest NSAIDs Players: Market Share by Revenue in NSAIDs in 2024

Figure 22. NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global NSAIDs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America NSAIDs Sales Market Share by Country (2020-2031)

Figure 25. North America NSAIDs Revenue Market Share by Country (2020-2031)

Figure 26. U.S. NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe NSAIDs Sales Market Share by Country (2020-2031)

Figure 29. Europe NSAIDs Revenue Market Share by Country (2020-2031)

Figure 30. Germany NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific NSAIDs Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific NSAIDs Revenue Market Share by Region (2020-2031)

Figure 37. China NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America NSAIDs Sales Market Share by Country (2020-2031)

Figure 48. Latin America NSAIDs Revenue Market Share by Country (2020-2031)

Figure 49. Mexico NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa NSAIDs Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa NSAIDs Revenue Market Share by Country (2020-2031)

Figure 54. Turkey NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of NSAIDs by Type (2020-2031)

Figure 58. Global Revenue Market Share of NSAIDs by Type (2020-2031)

Figure 59. Global NSAIDs Price (USD/Pcs) by Type (2020-2031)

Figure 60. Global Sales Market Share of NSAIDs by Application (2020-2031)

Figure 61. Global Revenue Market Share of NSAIDs by Application (2020-2031)

Figure 62. Global NSAIDs Price (USD/Pcs) by Application (2020-2031)

Figure 63. NSAIDs Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-16160

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-10G2665

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions